How often and in what way do you monitor patients who are receiving teprotumumab (Tepezza) for thyroid eye disease?
1 Answer
Mednet Member
Ophthalmology · Jackson Eye Associates
Answered on
A week or two after completion unless having an issue.
Join for free or sign in to see the full answer